Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors

(University of Texas M. D. Anderson Cancer Center) MD Anderson researchers discovered that a combination of immunotherapy and targeted therapies that block normal DNA damage repair, such as PARP inhibitors, achieved dramatic tumor reduction in mouse models of small cell lung cancer.